Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

Share Price is delayed by 15 minutes
Get Live Data
1,885.00    -14.00 (-0.74%)
Bid:
1,885.00
Ask:
1,886.00
Spread: 1.00 (0.053%)
Market Cap: £6.04b
HSX Live PriceLast checked at - London Stock Exchange

Intraday Hiscox Share Chart

Annual Report

11 Mar 2020 14:36

RNS Number : 8152F
Hiscox Ltd
11 March 2020
 

Hiscox Ltd

(the 'Company')

2019 Annual Report

Hamilton, Bermuda - in accordance with Listing Rule 9.6.1 a copy of the Company's Annual Report and Accounts for the year ended 31 December 2019 has been submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM

A copy can be viewed on the Company's web site: www.hiscoxgroup.com/investors

Information required under Disclosure and Transparency Rule 6.3.5 - Extracts from the 2019 Annual Report

This announcement should be read in conjunction with the Company's preliminary results announcement on 2 March 2020. Together, these announcements constitute the information required by DTR 6.3.5 to be communicated to the media in full unedited text through a Regulatory Information Service. This information is not a substitute for reading the Company's 2019 Annual Report.

Directors' responsibilities statement

The Board is responsible for ensuring the maintenance of proper accounting records which disclose with reasonable accuracy the financial position of the Group. It is required to ensure that the financial statements present a fair view for each financial period. The Directors explain in the Annual Report their responsibility for preparing the Annual Report and Accounts. We confirm that to the best of our knowledge:

 

· the financial statements, prepared in accordance with the International Financial Reporting Standards (IFRS) as adopted by the European Union, give a true and fair view, in all material respects, the assets, liabilities, financial position and profit or loss of the Company and the undertakings included in the consolidation taken as a whole; and

· the management report includes a fair review of the development and performance of the business and the position of the Company and the undertakings included in the consolidation taken as a whole, together with a description of the principal risks and uncertainties that they face.

 

The Directors responsible for authorising the responsibility statement on behalf of the Board are the Chairman, Robert Childs, and the Chief Financial Officer, Hamayou Akbar Hussain. The statements were approved for issue on 2 March 2020.

 

Principal risks and uncertainties

Key risks

As an insurance group, specific risks related to our business include:

 

Strategic risk

The possibility of adverse outcomes resulting from ineffective business plans and strategies, decision-making, resource allocation or adaptation to changes in the business environment. The Group's continuing success depends on how well we understand our clients, markets and the various internal and external factors affecting our business, and having a strategy in place to address risks and opportunities arising out of this. Not having the right strategy could have a detrimental impact on profitability, capital position, market share and reputation.

 

Underwriting risk

The risk that insurance premiums prove insufficient to cover future insurance claims and associated expenses. Likely causes include failing to price policies adequately, making poor risk selection decisions, allowing insurance exposures to accumulate to an unacceptable level, or accepting underwriting risks outside of agreed underwriting parameters. This includes people, process and system risks directly related to underwriting, such as human error in paying invalid claims or misquoting premium prices.

 

Reserving risk

The Group makes financial provisions for unpaid claims, defence costs and related expenses to cover liabilities both from reported claims and from 'incurred but not reported' (IBNR) claims. Reserving risk relates to the possibility of unsuitable case reserves and/or insufficient outstanding reserves being in place to meet incurred losses and associated expenses, which could affect the Group's future earnings and capital.

 

Credit risk

The risk of a reinsurance counterparty being subject to a default or downgrade that might cause them to renege on a reinsurance contract or alter the terms of an agreement. The Group buys reinsurance as a protection, but if our reinsurers found themselves unable to meet their obligations to us, this could put a strain on our earnings and capital and harm our financial condition and cash flows. Similarly, if a broker were to default, causing them to fail to pass premiums to us or pass the claims payment to a policyholder, this could result in Hiscox losing money.

 

Market risk

The threat of unfavourable or unexpected movements in the value of the Group's assets or the income expected from them. It includes risks related to investments - for example, losses within a given investment strategy, exposure to inappropriate assets or asset classes, or investments that fall outside of authorised strategic asset allocation or tactical asset allocation limits. It also includes issues of liquidity, which could result in the Group being unable to meet cash requirements from available resources within the appropriate timescales, such as being unable to pay liabilities to customers or other creditors when they fall due.

 

Operational risk

The risk of direct or indirect loss resulting from internal processes, people or systems, or from external events. This includes cyber security risk, which is the threat posed by the higher maturity of attack tools and methods and the increased motivation of cyber attackers, in conjunction with a failure to implement or maintain the systems and processes necessary to protect the confidentiality, integrity or availability of information and data. Operational risk also covers the potential for financial losses, information and cyber security risks which have legal, regulatory and reputational consequences, for example major IT, systems or service failures.

 

Regulatory, legal and tax governance

This relates to the business failing to act in accordance with its applicable regulatory requirements in all its applicable jurisdictions, or a deterioration in the quality of our relationship with one or more regulators. Legal risk is the risk of acting contrary to the relevant legal requirements in any of the jurisdictions in which we operate, while tax governance risk covers the consequences of any failure to act in accordance with relevant taxation laws or adapt to changes in taxation.

 

Related party transactions

Details of the remuneration of the Group's key personnel, presented in Sterling, are shown in the annual report on remuneration 2019 on pages 68 to 81. A number of the Group's key personnel hold insurance contracts with the Group, all of which are on normal commercial terms and are not material in nature.

 

The following transactions were conducted with related parties during the year.

 

(a) Syndicate 33 at Lloyd's

Related-party balances between Group companies and Syndicate 33 reflect the 27.4% interest(2018: 27.4%) that the Group does not own, and are as follows.

 

 

Transactions in the income

statement for the year ended

 

Balances outstanding

(payable) at

 

31 December

2019

$m

31 December

2018

(restated)*

$m

 

31 December

2019

$m

31 December

2018

$m

Hiscox Syndicates Limited

3.3

9.6

 

0.5

6.4

Hiscox Group insurance carriers

(34.6)

(14.3)

 

(130.5)

(67.4)

Hiscox Group insurance intermediaries

5.8

3.5

 

(6.7)

(6.9)

Other Hiscox Group companies

31.1

31.6

 

0.4

10.5

 

5.6

30.4

 

(136.3)

(57.4

*Following a review, the 2018 comparatives for transactions in the income statement have been restated to include Hiscox Underwriting Group Services Limited, under other Hiscox Group companies. There is no impact on the reported Group's balance sheet, income statement and cash flow statement.

 

(b) Transactions with associates

Certain companies within the Group conduct insurance and other business with associates. These transactions arise in the normal course of obtaining insurance business through brokerages, and are based on arm's length arrangements.

 

 

2019

$m

 

2018

$m

Gross premium income achieved through associates

13.7

1.5

Commission expense charged by associates

3.6

5.1

Amounts payable to associates at 31 December

-

-

Amounts receivable through associates at 31 December

51.5

41.1

 

Details of the Group's associates are given in note 14.

 

(c) Internal reinsurance arrangements

During the current and prior year, there were a number of reinsurance arrangements entered into in the normal course of trade between various Group companies. The related results of these transactions have been eliminated on consolidation.

 

 

Marc Wetherhill

Company Secretary

Hiscox Ltd

11 March 2020

+1 441 278 8300

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACSFLFVSVLILLII
Date   Source Headline
9th Mar 20233:46 pmRNSDirector/PDMR Shareholding
9th Mar 20237:00 amRNSSyndicates 33 and 6104 – results and estimates
8th Mar 20237:01 amRNSFull Year Results
8th Mar 20237:00 amRNSRobert Childs to retire from the Board as Chairman
2nd Mar 20237:00 amRNSTotal Voting Rights to 28 February 2023
1st Feb 20234:55 pmRNSTotal Voting Rights
16th Jan 20233:13 pmRNSDirector/PDMR Shareholding
13th Jan 20236:12 pmRNSAveva Group
7th Dec 20222:21 pmRNSDirector/PDMR Shareholding
1st Dec 202212:45 pmRNSTotal Voting Rights
28th Nov 20227:00 amRNSDirector PDMR Shareholding
14th Nov 202211:08 amRNSSyndicates 33 and 6104 – results and estimates
2nd Nov 20227:00 amRNSQ3 2022 Trading Statement
1st Nov 20224:19 pmRNSTotal Voting Rights
3rd Oct 20225:06 pmRNSTotal Voting Rights
26th Sep 20224:09 pmRNSDirector/PDMR Shareholding
22nd Sep 202211:00 amRNSDirector/PDMR Shareholding
15th Sep 20222:13 pmRNSApplication to be Admitted to the Official List
7th Sep 202212:04 pmRNSAnnouncement of the Scrip Reference Share price
6th Sep 20225:10 pmRNSDirector/PDMR Shareholding
1st Sep 20222:04 pmRNSTotal Voting Rights
12th Aug 20221:38 pmRNSDirector PDMR Shareholding
10th Aug 202212:29 pmRNSSyndicate Results
9th Aug 202211:05 amRNSDirector/PDMR Shareholding
3rd Aug 20227:00 amRNSInterim Report
6th Jul 202211:35 amRNSTotal Voting Rights
15th Jun 20222:05 pmRNSDirector/PDMR Shareholding
9th Jun 20221:09 pmRNSApplication to be Admitted to the Official List
31st May 20223:29 pmRNSAnnouncement of Scrip Reference Share Price
17th May 20225:30 pmRNSDirector/PDMR Shareholding
13th May 20223:30 pmRNSAppointment of Paul Cooper
13th May 20223:15 pmRNSAGM Results
10th May 202210:38 amRNSSyndicates 33 and 6104 – results and estimates
5th May 20227:00 amRNSTrading Statement
3rd May 202212:27 pmRNSTotal Voting Rights
21st Apr 20221:32 pmRNSTR-1 Standard form-notification major shareholding
11th Apr 20224:45 pmRNSNotice of 2022 Annual General Meeting
11th Apr 20222:43 pmRNSDirector/PDMR Shareholding
7th Apr 202211:07 amRNSDirector/PDMR Shareholding
1st Apr 202212:29 pmRNSTotal Voting Rights
29th Mar 20224:47 pmRNSDirector PDMR Shareholding
11th Mar 20224:27 pmRNS2021 Annual Report and Accounts
7th Mar 20226:10 pmRNSDirector/PDMR Shareholding
4th Mar 202210:55 amRNSSyndicates 33 and 6104 – results and estimates
2nd Mar 20227:00 amRNSFull Year Results
1st Mar 202212:15 pmRNSTotal Voting Rights
2nd Feb 20227:42 amRNSTR-1 Standard Form-Notification Major Shareholding
1st Feb 20225:03 pmRNSDirector/PDMR Shareholding
1st Feb 20225:03 pmRNSTotal Voting Rights
4th Jan 20227:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.